Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
NCT: NCT06360380 · RECRUITING
Brief Summary
The REFORM-HF study aims to test a new technology, AQUAPASS, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure. Patients will wear a lightweight suit that helps remove excess fluids through their sweat. The investigators want to see if the AQUAPASS system can remove an additional 500mL of fluids during treatment, alongside patients' regular medications like diuretics. Participants will be treated in the hospital or in the outpatient clinic.
Frequently Asked Questions
What is Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System?
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System is a clinical trial registered under NCT06360380. Current status: RECRUITING.
What is the status of NCT06360380?
The current status of NCT06360380 (Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System) is: RECRUITING.
When did Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System start?
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System started on 2024-08-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.